Delayed Hemolytic Transfusion Reaction/Hyperhemolysis Syndrome in Children With Sickle Cell Disease, PEDIATRICS, vol.111, issue.6, pp.661-666, 2003. ,
DOI : 10.1542/peds.111.6.e661
Current issues with blood transfusions in sickle cell disease, Seminars in Hematology, vol.38, issue.1, pp.14-22, 2001. ,
DOI : 10.1016/S0037-1963(01)90056-3
Severe Neurologic Complication After Delayed Hemolytic Transfusion Reaction in 2 Children With Sickle Cell Anemia, Journal of Pediatric Hematology/Oncology, vol.30, issue.12, pp.928-958, 2008. ,
DOI : 10.1097/MPH.0b013e31818c9172
Delayed hemolytic transfusion reaction in children with sickle cell disease, Haematologica, vol.96, issue.6, pp.801-808, 2011. ,
DOI : 10.3324/haematol.2010.038307
URL : https://hal.archives-ouvertes.fr/inserm-00607864
Relevance of RH variants in transfusion of sickle cell patients, Transfusion Clinique et Biologique, vol.18, issue.5-6, pp.527-562, 2011. ,
DOI : 10.1016/j.tracli.2011.09.001
Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death, Transfusion, vol.2007, issue.9, pp.1785-92, 2009. ,
DOI : 10.1111/j.1537-2995.2009.02199.x
Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.Transfusion, 2002. ,
Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells, Transfusion, vol.37, issue.4, pp.376-381, 1997. ,
DOI : 10.1046/j.1537-2995.1997.37497265337.x
Delayed Hemolytic Transfusion Reaction Presenting as Sickle-Cell Crisis, Annals of Internal Medicine, vol.93, issue.2, pp.231-235, 1980. ,
DOI : 10.7326/0003-4819-93-2-231
Delayed hemolytic transfusion reaction presenting as a painful crisis in a patient with sickle cell anemia, Sao Paulo Medical Journal, vol.117, issue.1, pp.38-47, 1999. ,
DOI : 10.1590/S1516-31801999000100007
Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management, Blood, vol.120, issue.3, pp.528-565, 2012. ,
DOI : 10.1182/blood-2011-11-327361
URL : https://hal.archives-ouvertes.fr/inserm-00696264
Relevance of blood groups in transfusion of sickle cell disease patients, Comptes Rendus Biologies, vol.336, issue.3, pp.152-160 ,
DOI : 10.1016/j.crvi.2012.09.011
Red blood cell alloimmunization in sickle cell disease patients in Uganda, Transfusion, vol.48, issue.1, pp.20-25, 2010. ,
DOI : 10.1111/j.1537-2995.2009.02435.x
Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom, British Journal of Haematology, vol.81, issue.3, pp.661-665, 2001. ,
DOI : 10.1056/NEJM199507273330402
Molecular basis of the altered antigenic expression of RhD in weak D(Du) and RhC/e in RN phenotypes, Blood, vol.87, issue.11, pp.4853-4861, 1996. ,
DAK, a new low-incidence antigen in the Rh blood group system, Transfusion, vol.83, issue.10, pp.1394-1397, 2003. ,
DOI : 10.1046/j.1537-2995.1999.39111259.x
in an Alloimmunized Patient With a Sickle Cell Syndrome, American Journal of Clinical Pathology, vol.108, issue.6, pp.658-661, 1997. ,
DOI : 10.1093/ajcp/108.6.658
Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease, The American Journal of the Medical Sciences, vol.339, issue.3, 2010. ,
DOI : 10.1097/MAJ.0b013e3181c70e14
Particularit??s immunoh??matologiques dans les populations africaines et antillaises. Implications transfusionnelles, Transfusion Clinique et Biologique, vol.10, issue.3, pp.185-191, 2003. ,
DOI : 10.1016/S1246-7820(03)00042-9
The sickle cell hemolytic transfusion reaction syndrome, Transfusion, vol.37, issue.4, pp.382-392, 1997. ,
DOI : 10.1046/j.1537-2995.1997.37497265338.x
Mechanisms of Suicidal Erythrocyte Death, Cellular Physiology and Biochemistry, vol.15, issue.5, pp.195-202, 2005. ,
DOI : 10.1159/000086406
Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells, Transfusion, vol.37, issue.4, pp.376-81, 1997. ,
DOI : 10.1046/j.1537-2995.1997.37497265337.x
Hyperhemolysis syndrome in anemia of chronic disease, Transfusion, vol.74, issue.12, pp.1930-1933, 2005. ,
DOI : 10.1542/peds.111.6.e661
Hyperhemolytic transfusion reaction in sickle cell disease, Transfusion, vol.73, issue.3, pp.323-331, 2001. ,
DOI : 10.1054/blre.1999.0121
Sickle cell anemia as an inflammatory disease, Journal of Clinical Investigation, vol.106, issue.3, pp.337-338, 2000. ,
DOI : 10.1172/JCI10726
Cell Response to Surgery, Archives of Surgery, vol.141, issue.11 ,
DOI : 10.1001/archsurg.141.11.1132
The role of inflammation in alloimmunization to antigens on transfused red blood cells, Current Opinion in Hematology, vol.15, issue.6, pp.631-635, 2008. ,
DOI : 10.1097/MOH.0b013e328313695e
HLA-B35 is associated with red cell alloimmunization in sickle cell disease, Clinical Immunology and Immunopathology, vol.38, issue.2, pp.178-183, 1986. ,
DOI : 10.1016/0090-1229(86)90136-4
Alloantibody responses in multiply transfused sickle cell patients, Tissue Antigens, vol.54, issue.4, pp.161-166, 1987. ,
DOI : 10.1111/j.1399-0039.1987.tb01615.x
HLA type and risk of alloimmunization in sickle cell disease, American Journal of Hematology, vol.49, issue.7, pp.462-464, 2009. ,
DOI : 10.1002/ajh.21442
The Endothelial Biology of Sickle Cell Disease: Inflammation and a Chronic Vasculopathy, Microcirculation, vol.11, issue.2, pp.129-151, 2004. ,
DOI : 10.1080/mic.11.2.129.151
Post-Transfusion Hyperhaemolysis in a Patient with Sickle Cell Disease: Use of Steroids and Intravenous Immunoglobulin to Prevent Further Red Cell Destruction, Vox Sanguinis, vol.67, issue.suppl, pp.355-357, 1995. ,
DOI : 10.1111/j.1423-0410.1995.tb00373.x
Use of Intravenous Immunoglobulin and Intravenous Methylprednisolone in Hyperhaemolysis Syndrome in Sickle Cell Disease, Hematology, vol.73, issue.5-6, pp.433-436, 2004. ,
DOI : 10.1212/01.WNL.0000068335.01620.9D
Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review, Transfusion, vol.73, issue.6, pp.1231-1238, 2008. ,
DOI : 10.1002/1096-8652(200102)66:2<151::AID-AJH1035>3.3.CO;2-H
Delayed hemolytic transfusion reaction in sickle cell anemia, Transfusion, vol.20, issue.4, p.477, 1980. ,
DOI : 10.1046/j.1537-2995.1980.20480260288.x
Red blood cell alloimmunization in sickle cell disease patients in Uganda, Transfusion, vol.48, issue.1, pp.20-25, 2010. ,
DOI : 10.1111/j.1537-2995.2009.02435.x
Hyperhemolytic transfusion reaction attributable to anti-Fy3 in a patient with sickle cell disease, Immunohematology, vol.24, issue.2, pp.45-51, 2008. ,
Fatal delayed transfusion reaction in a sickle cell anemia patient with Serratia marcescens sepsis, J Natl Med Assoc, vol.98, issue.10, pp.1697-1706, 2006. ,
Anti-s Antibody-Associated Delayed Hemolytic Transfusion Reaction in Patients With Sickle Cell Anemia, Journal of Pediatric Hematology/Oncology, vol.21, issue.1, pp.70-73, 1999. ,
DOI : 10.1097/00043426-199901000-00016
Difficulties in identifying antibodies in the Dombrock blood group system in multiply alloimmunized patients.Transfusion, pp.11-12, 1998. ,
Delayed hemolytic transfusion reaction due to anti-Go(a), an antibody against the low-prevalence Gonzales antigen, Am J Hematol, 1996. ,
Case report and review: alloimmunization, delayed hemolytic transfusion reaction, and clinically significant anti-Yt (a) in a patient with Beta-thalassemia/sickle cell anemia, Immunohematology, vol.7, issue.4, pp.102-108, 1991. ,
and Anti-Fy5, Vox Sanguinis, vol.52, issue.1, pp.35-41, 1988. ,
DOI : 10.1111/j.1423-0410.1988.tb04685.x
A clinically significant anti-N in a patient whose red cells were negative for N and U antigens. Transfusion, pp.377-80, 1985. ,
The second example of anti-Duffy5. Transfusion, pp.358-60, 1980. ,
Indications for red cell transfusion in sickle cell disease, Seminars in Hematology, vol.38, issue.1 1, pp.5-13, 2001. ,
DOI : 10.1016/S0037-1963(01)90055-1
Delayed hemolytic transfusion reaction with hyperhemolysis after first red blood cell transfusion in child with ??-thalassemia: challenges in treatment, Transfusion, vol.11, issue.2, pp.429-461, 2010. ,
DOI : 10.1111/j.1537-2995.2009.02399.x
Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease, Haematologica, vol.92, issue.12, pp.132-137, 2007. ,
DOI : 10.3324/haematol.12074
Use of intravenous immunoglobulin and intravenous methylprednisolone in hyperhaemolysis syndrome in sickle cell disease. Hematology, pp.5-6433, 2004. ,
High-Dose Intravenous Methylprednisolone Therapy for Pain in Children and Adolescents with Sickle Cell Disease, New England Journal of Medicine, vol.330, issue.11, pp.733-740, 1994. ,
DOI : 10.1056/NEJM199403173301101
Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease, Blood, vol.92, issue.9, pp.3082-3091, 1998. ,
Co-existent sickle cell disease and juvenile rheumatoid arthritis. T wo cases with delayed diagnosis and severe destructive arthropathy, J Rheumatol, vol.28, issue.9, pp.2125-2133, 2001. ,
Sickle cell crisis following intraarticular steroid therapy for rheumatoid arthritis, Arthritis & Rheumatism, vol.9, issue.9, pp.1065-1073, 1987. ,
DOI : 10.1002/art.1780300916
Autoimmune Liver Disease in Three Children with Sickle Cell Disease, Journal of Pediatric Gastroenterology and Nutrition, vol.42, issue.1, pp.104-112, 2006. ,
DOI : 10.1097/01.MPG.0000162480.81900.AF
Steroid treatment in children with sickle-cell disease, Haematologica, vol.92, issue.3, pp.425-431, 2007. ,
DOI : 10.3324/haematol.10800
A Single-Institution Experience With Treatment of Severe Acute Chest Syndrome: Lack of Rebound Pain With Dexamethasone Plus Transfusion Therapy, Journal of Pediatric Hematology/Oncology, vol.30, issue.4, pp.322-327, 2008. ,
DOI : 10.1097/MPH.0b013e3181647bb2
Combination Erythropoietin-Hy droxyurea Therapy in Sickle Cell Disease: NIH experience and literature review, Haematologica, vol.91, issue.8, pp.1076-1083, 2006. ,